Participant characteristics
| Variable | Intervention, n (%)* n = 158 | Control, n (%)* n = 154 |
|---|---|---|
| Female† | 101 (63.9) | 93 (60.4) |
| Age, yr, mean ± SD† | 78.06 ± 6.3 | 79.06 ± 6.6 |
| Age > 80† | 54 (34.2) | 64 (41.6) |
| Highest level of education† | n = 153 | n = 145 |
| High school | 60 (38.0) | 70 (45.5) |
| Post-secondary and higher | 93 (58.9) | 75 (48.7) |
| Country of birth: Canada† | 83 (59.3) n = 140 | 84 (60.9) n = 138 |
| European or white ethnicity† | 111 (88.8) n = 125 | 109 (86.5) n = 126 |
| Main language: English† | 131 (94.2) n = 139 | 126 (91.3) n = 138 |
| Marital status† | n = 137 | n = 134 |
| Married or common law | 70 (51.1) | 66 (49.3) |
| Widowed, divorced, separated, single or never married | 67 (48.9) | 68 (50.8) |
| Chronic conditions or diseases‡ | ||
| Hypertension | 81 (66.9) n = 121 | 88 (66.7) n = 132 |
| Osteoarthritis | 43 (35.3) n = 122 | 61 (46.2) n = 132 |
| Diabetes | 37 (30.3) n = 122 | 34 (25.8) n = 132 |
| Heart disease§ | 41 (33.6) n = 122 | 57 (43.2) n = 132 |
| Cancer | 26 (21.9) n = 119 | 40 (30.3) n = 132 |
| Chronic obstructive pulmonary disease or lung disease | 14 (11.9) n = 118 | 18 (13.6) n = 132 |
| Stroke or cerebrovascular disease | 8 (6.6) n = 122 | 8 (6.1) n = 131 |
| Extent of comorbidityঠ| n = 122 | n = 132 |
| 1–2 comorbidities | 86 (70.5) | 85 (64.4) |
| ≥ 3 comorbidities | 36 (29.5) | 47 (35.6) |
| Years with clinic‡ | n = 158 | n = 153 |
| < 5 | 28 (17.7) | 23 (17.0) |
| ≥ 5 | 130 (82.3) | 127 (83.0) |
| No. of prescription medications, mean ± SD‡ | 5.39 ± 4.2 n = 156 | 5.64 ± 3.8 n = 150 |